Alpine Partners VI »

Inhibrx Biosciences shares owned by Alpine Partners VI

Quarter-by-quarter ownership of Inhibrx Biosciences (INBX) shares owned by Alpine Partners VI from 13F filings

Historical chart of Alpine Partners VI investment in Inhibrx Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Inhibrx Biosciences held by Alpine Partners VI consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inhibrx Biosciences by Alpine Partners VI

Quarter filed Position value Share count Share price at filing
2024-06-30 $176k 12k 14.17

More positions owned by Alpine Partners VI

Immunovant (IMVT)
Cornerstone Strategic Value (CLM)
Microstrategy Cl A New (MSTR)
Robinhood Mkts Com Cl A (HOOD)
Cornerstone Total Rtrn Fd In (CRF)
Archer Aviation Com Cl A (ACHR)
Microsoft Corporation (MSFT)
Live Nation Entertainment In Note 2.000% 2/1
Rivian Automotive Note 4.625% 3/1
Vishay Intertechnology Note 2.250% 6/1
Veeco Instrs Inc Del Note 2.875% 6/0
Alphabet Cap Stk Cl A (GOOGL)
Snap Note 0.125% 3/0
Burlington Stores Note 2.250% 4/1
Ncl Corp Note 5.375% 8/0

View all positions for Alpine Partners VI

Top funds holding Inhibrx Biosciences

Viking Global Investors
Perceptive Advisors
BlackRock
BlackRock
Sofinnova Ventures
Vanguard Group
Slotnik Capital
Geode Capital Management
Morgan Stanley
Caption Management
Kennedy Capital Management
Arrowpoint Asset Management
Susquehanna International
State Street Corporation
Schonfeld Strategic Advisors

View all funds holding Inhibrx Biosciences